Skip to main content

Table 1 Baseline Characteristics of Subjects

From: Development of the ATAQ-IPF: a tool to assess quality of life in IPF

Male, % 82
Ethnicity, %  
   Caucasian 94
   Black 1
   Other 5
Age yrs 69.3 (7.6)
Smoking status, %  
   Past 64
   Never 36
Had surgical biopsy, % 56
Time since diagnosis, yrs 2.9 (2.8)
Using supplemental O2, %  
   Not at all 39
   Exertion and sleep 31
   Continuous 30
FVC% 65 (17)
DLCO% 39 (15)
6MWD, feet 1147 (441)
Taking IPF medications, %  
   Prednisone 24
   Azathioprine 14
   N-acetyl cysteine 24
Carries a diagnosis of ___, %  
   Emphysema (by HRCT) 15
   PH by echocardiogram 31
   Stable CAD 24
ATAQ-IPF scores: Raw T
   Cough 16 (7)
   Dyspnea 19 (6)
   Forethought 14 (6)
   Sleep 16 (5)
   Mortality 17 (5)
   Exhaustion 15 (5)
   Emotional Well-Being 20 (6)
   Social Participation 15 (5)
   Finances 17 (7)
   Independence 14 (5)
   Sexual Health 15 (6)
   Relationships 17 (4)
   Therapies 16 (4)
   Total 210 (46)
  1. Data presented as % or mean (standard deviation); O2 = oxygen; FVC% = percent predicted forced vital capacity; DLCO% = percent predicted diffusing capacity of the lung for carbon monoxide; COPD = chronic obstructive pulmonary disease; HRCT = high-resolution computed tomography scan; PH = pulmonary hypertension; CAD = coronary artery disease